Analyst Ratings for Impax Laboratories Inc. (IPXL)

Updated: 2017-07-27

An average rating of Hold has been given to Impax Laboratories Inc. (NASDAQ:IPXL) by analysts covering the stock. A consensus rating of Hold was previously issued for IPXL last month.

3 analysts declared IPXL a buy, 0 gave an overweight rating, 8 issued a hold rating, 0 gave an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 1 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has decreased by 1.

IPXL was given price targets by several analysts. The highest price target was 21, implying a possible profit of 7.69 percent. The lowest price target was 12, implying a possible loss of -38.46 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -12.5 percent. Meanwhile, fiscal year estimates have been revised upwards by 1.55 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -8.39 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. During this time, 3 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

IPXL has traded between a high of 31.85 and a low of 7.75 over the past year. The current market price is above the trailing year's low by 151.61 percent, and 38.78 percent lower than its 52-week high. IPXL has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The IPXL value stock report compares IPXL to some of its peers using value stock charts. The market cap of IPXL is $1.46 billion. IPXL will post this quarters earnings in days, on 0000-00-00.